True about HUS –
**Core Concept**
Hemolytic Uremic Syndrome (HUS) is a complex condition characterized by the **triad** of hemolytic anemia, acute kidney injury, and thrombocytopenia. It is often associated with **Shiga toxin-producing Escherichia coli (E. coli)** infections. The underlying pathophysiology involves **endothelial damage** and **microangiopathic hemolytic anemia**.
**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of HUS, which involves **Shiga toxin** damaging the **endothelial cells** lining the small blood vessels, leading to **thrombotic microangiopathy**. This results in **mechanical shearing** of red blood cells, causing **schistocyte formation** and **hemolytic anemia**. The kidneys are particularly affected, leading to **acute kidney injury**.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it is not a characteristic feature of HUS.
**Option B:** Incorrect as it does not accurately describe the primary pathophysiological mechanism of HUS.
**Option C:** Incorrect because, although it may be related to kidney function, it is not a defining characteristic of HUS.
**Option D:** Incorrect as it is not directly related to the core pathophysiology of HUS.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that HUS is a medical emergency requiring prompt **plasma exchange** and **supportive care** to manage **renal failure** and prevent long-term **kidney damage**.
**Correct Answer:** D. Characterized by microangiopathic hemolytic anemia.